about
The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica.Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of AtherosclerosisThe Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients.Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers.Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies.Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension.Morning pentraxin3 levels reflect obstructive sleep apnea-related acute inflammationSoluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients.Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia.Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney diseaseAssociations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study.Pentraxin 3 as a Novel Marker in Cardiovascular Diseases?Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosisThe acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury.Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients.Novel serum biomarkers in pulmonary arterial hypertension.Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs.Pathophysiology of thrombosis in myeloproliferative neoplasms.Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.Putting it into perspective: multimarker panels for cardiovascular disease risk assessment.The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients.Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome.Plasma Pentraxin 3 as a biomarker of metabolic syndrome.Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients.Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus.
P2860
Q28118397-FCACD7D9-467B-458C-ABDB-F3C188842D33Q33397083-FF9631E5-FB96-4A5E-A236-9BF8E890523DQ33748025-F8A69A45-6BF1-467C-87BC-0C7767B54EBBQ34021175-73A7D367-C3DC-4B8C-89D9-983E2B2E0D40Q34042106-B3CFCBE3-D526-4EC5-A185-73A5C1C9F597Q34154838-8809A66C-2BD3-4FBE-8D5A-C814CDD38C37Q34430183-18E4D6D3-EA18-431E-BDBA-F89A6C92D259Q34519002-85EDC96E-2724-4E02-8B1F-5E0A80879938Q34751855-21538FFA-949D-4FE8-991D-75675E1AE799Q35026270-35F2F84E-96B2-46BC-925C-DD41AD64F999Q35227705-48CF381F-E547-4591-B286-02AC17251488Q36026534-0D926E34-A73D-4BCA-9F0F-CB38A6D2592CQ36164346-A49DBC4B-DF6B-4A8B-A4C0-346E855D0492Q36557903-C59298B7-91EE-435C-B1C9-2E046B2065ADQ36736700-B6AD4D42-B93D-41AC-A54E-B1A771BD2040Q37141153-774CD922-B380-4A88-AFE3-9DDA27D41324Q37155352-37C6C48C-AD0C-4563-B7F0-DAD07FCFBB28Q37160916-E54E3DFB-B5D1-4AA3-B503-04E3CD402454Q37627769-5F4593DC-1541-4742-8BB9-D9EA03E723BAQ37629231-E9654AD0-A4C1-4B77-BD49-724D21299841Q38262569-C10A811C-D351-415C-9116-078847344B0BQ39252622-1BDA78EB-5429-49E9-BD51-E3C616DA7625Q39283041-9F4B8E49-BA11-445C-AA21-76808E8A1D9FQ39564366-6E7A3AB5-8875-4C86-8DB4-1B9695B19826Q42586757-9BC7F818-D2CE-4FD6-AEE9-865125AD615FQ43142703-DC384983-15E7-4858-8AE6-F36E6F91973DQ43992427-FBA8E279-17C3-407F-81BB-A724820D245EQ44456570-AD462CEF-5FC2-4EDE-A4B5-EBD289938412Q44605195-8701303B-830C-46AC-A306-C0D3B51E2E5BQ44792456-BF810208-3FC8-406B-82FA-4336F5EA6798Q45377428-2E2364DA-FAB8-44CB-916B-D3B827210DE1Q46315734-B6014297-D3AB-4B39-84D4-54FF8F964CF8Q51064056-0F8BB25D-CD0B-47F0-85B8-20D220516CCBQ51067081-03537F79-C2D4-43C2-8B49-59E845A653ADQ51595971-42B2529F-206F-46D0-8987-574A6B9C168AQ53985364-A42DE131-4E3C-40BA-ACCC-33501245D774Q55024341-3C956FE7-02F9-4DBB-9B48-E98B47C6535C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The long pentraxin PTX3 in vascular pathology.
@ast
The long pentraxin PTX3 in vascular pathology.
@en
type
label
The long pentraxin PTX3 in vascular pathology.
@ast
The long pentraxin PTX3 in vascular pathology.
@en
prefLabel
The long pentraxin PTX3 in vascular pathology.
@ast
The long pentraxin PTX3 in vascular pathology.
@en
P2093
P50
P1476
The long pentraxin PTX3 in vascular pathology.
@en
P2093
Giuseppe Peri
Roberto Latini
Yeny Martinez de la Torre
P304
P356
10.1016/J.VPH.2006.08.011
P577
2006-08-23T00:00:00Z